Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
3,288,318
-
Share change
-
-22,056
-
Total reported value
-
$12,166,000
-
Price per share
-
$3.70
-
Number of holders
-
13
-
Value change
-
-$114,849
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2022
As of 30 Jun 2022,
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,288,318 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Cormorant Asset Management, LP, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, STATE STREET CORP, MEITAV DASH INVESTMENTS LTD, ENVESTNET ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, ADVISOR GROUP HOLDINGS, INC., and MORGAN STANLEY.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.